These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36054655)

  • 21. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
    Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
    Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
    Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).
    Ólafsdóttir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlén E; Schwarcz E; Nyström T; Hellman J; Hirsch IB; Lind M
    Diabetes Obes Metab; 2021 Feb; 23(2):619-630. PubMed ID: 33200487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
    Leelarathna L; Sutton CJ; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Krishan A; Taxiarchi VP; Barnard-Kelly K; Elliott RA; Burns M; Camm M; Thabit H; Wilmot EG;
    Diabet Med; 2024 Mar; 41(3):e15249. PubMed ID: 37897112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked improvement in HbA
    Tyndall V; Stimson RH; Zammitt NN; Ritchie SA; McKnight JA; Dover AR; Gibb FW
    Diabetologia; 2019 Aug; 62(8):1349-1356. PubMed ID: 31177314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial.
    Aronson R; Brown RE; Chu L; Bajaj HS; Khandwala H; Abitbol A; Malakieh N; Goldenberg R
    Diabetes Obes Metab; 2023 Apr; 25(4):1024-1031. PubMed ID: 36546594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients.
    Mustonen J; Rautiainen P; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
    Acta Diabetol; 2023 Jul; 60(7):891-898. PubMed ID: 36977968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting.
    Brett McQueen R; Perez-Nieves M; Todd Alonso G; Fan L; Hankosky ER; Shah VN; Yan Y; Ellis SL; Juneja R
    Diabetes Res Clin Pract; 2024 Jun; 212():111690. PubMed ID: 38697300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
    Crabtree TSJ; Griffin TP; Yap YW; Narendran P; Gallen G; Furlong N; Cranston I; Chakera A; Philbey C; Karamat MA; Saraf S; Kamaruddin S; Gurnell E; Chapman A; Hussain S; Elliott J; Leelarathna L; Ryder REJ; Hammond P; Lumb A; Choudhary P; Wilmot EG;
    Diabetes Care; 2023 Oct; 46(10):1831-1838. PubMed ID: 37566697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
    Goldenberg RM; Aroda VR; Billings LK; Christiansen ASL; Meller Donatsky A; Parvaresh Rizi E; Podgorski G; Raslova K; Klonoff DC; Bergenstal RM
    Diabetes Obes Metab; 2021 Nov; 23(11):2572-2581. PubMed ID: 34322967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK.
    Broos B; Charleer S; Bolsens N; Moyson C; Mathieu C; Gillard P; De Block C
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3037-e3048. PubMed ID: 33740049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 37. Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers.
    Ng SM; Katkat N; Day H; Hubbard R; Quinn M; Finnigan L
    Diabet Med; 2022 Jul; 39(7):e14863. PubMed ID: 35488481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials.
    Liao B; Chen Y; Chigutsa F; Piras de Oliveira C
    Diabetes Obes Metab; 2021 Jul; 23(7):1571-1579. PubMed ID: 33687790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prepregnancy care in women with type 1 diabetes improves HbA
    Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
    Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.